Status:
COMPLETED
Characterisation of Heart Involvement in Fabry Disease With T1 Mapping
Lead Sponsor:
Manchester University NHS Foundation Trust
Collaborating Sponsors:
Northern Care Alliance NHS Foundation Trust
Conditions:
Fabry Disease
Eligibility:
All Genders
18+ years
Brief Summary
Fabry disease is a rare lysosomal storage disorder characterised by a genetic deficiency in the α-galactosidase enzyme. This deficiency leads to a progressive accumulation of a fatty substance, called...
Detailed Description
Anderson-Fabry disease (Fabry disease) is a genetic lysosomal storage disorder. Lysosomes are structures found within cells that contain enzymes which break down waste products and foreign material. I...
Eligibility Criteria
Inclusion
- Patients with Fabry disease Patients attending for a clinical cardiac MRI scan
Exclusion
- Patients who have a contraindication to cardiac MRI scanning (including pacemakers, defibrillators, intra-ocular metal, prohibitive intracranial aneurysm clips, severe claustrophobia, inability to lie flat).
Key Trial Info
Start Date :
March 12 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04708301
Start Date
March 12 2014
End Date
December 31 2020
Last Update
October 20 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Manchester Univiersty Foundation Trust
Manchester, United Kingdom, M239LT